Loading
Insider filings for Xanthic Biopharma Inc. (formerly Aurquest Resources Inc) are scarce in the SEDI feed, the latest one published on 14 March 2018. This page will fill in as new trades are disclosed. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
1 of 1 declaration
Xanthic Biopharma Inc., formerly Aurquest Resources Inc, is a biopharmaceutical company focused on developing innovative treatments. It is listed on the XTSE market.